224 related articles for article (PubMed ID: 33191070)
1. Clinical features of multiply recurrent retroperitoneal liposarcoma: A single-center experience.
Masaki N; Onozawa M; Inoue T; Kurobe M; Kawai K; Miyazaki J
Asian J Surg; 2021 Jan; 44(1):380-385. PubMed ID: 33191070
[TBL] [Abstract][Full Text] [Related]
2. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.
Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB
Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768
[TBL] [Abstract][Full Text] [Related]
3. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability.
Crago AM; Socci ND; DeCarolis P; O'Connor R; Taylor BS; Qin LX; Antonescu CR; Singer S
Clin Cancer Res; 2012 Mar; 18(5):1334-40. PubMed ID: 22241790
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes.
Ikoma N; Torres KE; Somaiah N; Hunt KK; Cormier JN; Tseng W; Lev D; Pollock R; Wang WL; Feig B
Ann Surg Oncol; 2015 Apr; 22(4):1068-72. PubMed ID: 25354575
[TBL] [Abstract][Full Text] [Related]
5. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
Singer S; Antonescu CR; Riedel E; Brennan MF
Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of primary and repeated recurrent retroperitoneal liposarcoma: outcomes after aggressive surgeries at a single institution.
Ishii K; Yokoyama Y; Nishida Y; Koike H; Yamada S; Kodera Y; Sassa N; Gotoh M; Nagino M
Jpn J Clin Oncol; 2020 Dec; 50(12):1412-1418. PubMed ID: 32699905
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of anlotinib in patients with unresectable or metastatic well-differentiated/dedifferentiated liposarcoma: a single-center retrospective study.
Li ZK; Liu J; Deng YT; Jiang Y
Anticancer Drugs; 2021 Feb; 32(2):210-214. PubMed ID: 33290314
[TBL] [Abstract][Full Text] [Related]
8. Paratesticular liposarcoma: a clinicopathologic study.
Montgomery E; Fisher C
Am J Surg Pathol; 2003 Jan; 27(1):40-7. PubMed ID: 12502926
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of prognostic factors for liposarcoma].
Zhang Q; Li JM; Liu JL; Wei YZ
Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):943-948. PubMed ID: 31874553
[No Abstract] [Full Text] [Related]
10. Atypical and malignant neoplasms showing lipomatous differentiation. A study of 111 cases.
Azumi N; Curtis J; Kempson RL; Hendrickson MR
Am J Surg Pathol; 1987 Mar; 11(3):161-83. PubMed ID: 3826477
[TBL] [Abstract][Full Text] [Related]
11. Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors.
Tropea S; Mocellin S; Damiani GB; Stramare R; Aliberti C; Del Fiore P; Rossi CR; Rastrelli M
Eur J Surg Oncol; 2021 May; 47(5):1201-1206. PubMed ID: 32950313
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
Adachi T; Oda Y; Sakamoto A; Saito T; Tamiya S; Masuda K; Tsuneyoshi M
Int J Surg Pathol; 2001 Apr; 9(2):99-109. PubMed ID: 11484509
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma.
Crago AM; Singer S
Curr Opin Oncol; 2011 Jul; 23(4):373-8. PubMed ID: 21552124
[TBL] [Abstract][Full Text] [Related]
14. Amplification of FRS2 in atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases.
Jing W; Lan T; Chen H; Zhang Z; Chen M; Peng R; He X; Zhang H
Histopathology; 2018 Jun; 72(7):1145-1155. PubMed ID: 29368794
[TBL] [Abstract][Full Text] [Related]
15. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
[TBL] [Abstract][Full Text] [Related]
16. Retroperitoneal Dedifferentiated Liposarcoma.
Dehner CA; Hagemann IS; Chrisinger JSA
Am J Clin Pathol; 2021 Oct; 156(5):920-925. PubMed ID: 34125170
[TBL] [Abstract][Full Text] [Related]
17. Optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma is suspected: a single-center study.
Rhu J; Cho CW; Lee KW; Park JB; Kim SJ
Int J Clin Oncol; 2019 May; 24(5):583-589. PubMed ID: 30604162
[TBL] [Abstract][Full Text] [Related]
18. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule.
Park JO; Qin LX; Prete FP; Antonescu C; Brennan MF; Singer S
Ann Surg; 2009 Dec; 250(6):977-82. PubMed ID: 19953716
[TBL] [Abstract][Full Text] [Related]
19. Primary retroperitoneal liposarcoma: clinical and histological analysis of ten cases.
Fernández-Ruiz M; Rodríguez-Gil Y; Guerra-Vales JM; Manrique-Municio A; Moreno-González E; Colina-Ruizdelgado F
Gastroenterol Hepatol; 2010 May; 33(5):370-6. PubMed ID: 20206410
[TBL] [Abstract][Full Text] [Related]
20. Retroperitoneal liposarcomas: the experience of a tertiary Asian center.
Lee SY; Goh BK; Teo MC; Chew MH; Chow PK; Wong WK; Ooi LL; Soo KC
World J Surg Oncol; 2011 Feb; 9():12. PubMed ID: 21284868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
